Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05921149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Apr 1, 2024 to May 25, 2024v4
  2. Start date: Dec 1, 2023 to Apr 1, 2024v3
  3. Start date: Aug 1, 2023 to Dec 1, 2023v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Endeavor Health
37 trials monitored
See 3 trials at risk
Ovarian Cancer
1,336 trials monitored
See 90 trials at risk
Rates of grade 3-4 toxicity with carboplatin and paclitaxel chemotherapy range 26-84%. Interventions to reduce toxicity are needed. Short term fasting protects against toxic effects of chemotherapy without decreasing efficacy. In a prospective clinical trial of breast cancer patients randomized to FMD or regular diet during chemotherapy, less antiemetic was required in the FMD group; radiographic and pathologic responses were better in this group. This trial tests whether platinum-taxane chemotherapy combined with a FMD in advanced and recurrent ovarian, fallopian tube and primary peritoneal cancer patients is associated with decreased toxicity and/ or improved tumor response to therapy.
Trial Details
NCT Number NCT05921149
Lead Sponsor Endeavor Health
Collaborators: L-Nutra Inc
Conditions
(from sponsor)		 Ovarian Cancer, Chemotherapeutic Toxicity
Related terms Ovarian Neoplasms
Enrollment 170 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov